Skip to main content
Clinical Trials/JPRN-UMIN000022930
JPRN-UMIN000022930
Completed
未知

The effect on bleeding complication occurred by hemostatic agents discontinuation in the percutaneous renal biopsy - Hemostatic agents discontinuation and bleeding complication

ational Hospital Organization Kyoto Medical Center0 sites100 target enrollmentJune 28, 2016
Conditionskidney disease

Overview

Phase
未知
Intervention
Not specified
Conditions
kidney disease
Sponsor
ational Hospital Organization Kyoto Medical Center
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 28, 2016
End Date
December 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Hospital Organization Kyoto Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who were punctured with bilateral kidney with sampling difficulty Patients who received erythrocyte transfusion before confirming hemoglobin concentration in four hours after renal biopsy

Outcomes

Primary Outcomes

Not specified

Similar Trials